HOWL Werewolf Therapeutics, Inc.
Fundamentals / CIK 0001785530 / USDWerewolf Therapeutics, Inc. reported $42.75M in total assets and a net loss of $28.12M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HOWL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$25.59M Operating profit
-
Net Income FY 2025-$28.12M GAAP bottom line
-
Diluted EPS FY 2025-$0.58 Split-adjusted
-
Free Cash Flow FY 2025-$60.29M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$41.87M Total debt: --
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $44.83M | $56.43M | $41.78M | $53.76M | $35.27M | $16.64M |
| Total Operating Expenses | $60.68M | $75.48M | $60.45M | $72.46M | $50.09M | $22.40M |
| Operating Income | -$60.68M | -$73.59M | -$40.50M | -$56.06M | -$50.09M | -$22.40M |
| EBITDA | -$59.04M | -$71.78M | -$38.74M | -$54.95M | -$49.87M | -$22.25M |
| Interest Income | $3.11M | $6.67M | $7.42M | $1.91M | -- | -- |
| Interest Expense | $5.27M | $4.66M | $3.14M | $0 | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- |
| Net Income | -$60.82M | -$70.52M | -$37.37M | -$53.81M | -$49.98M | -$15.04M |
| Basic EPS | -$1.32 | -$1.63 | -$1.05 | -$1.86 | -$10.94 | -$28.08 |
| Diluted EPS | -$1.33 | -$1.63 | -$1.05 | -$1.86 | -$10.94 | -$28.08 |
| Basic Shares Outstanding | 46.0M | 43.3M | 35.6M | 28.9M | 18.5M | 1.0M |
| Diluted Shares Outstanding | 46.8M | 43.9M | 35.6M | 28.9M | 18.5M | 1.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $2.17M | $6.16M | $8.18M | $6.93M | $11.63M | $13.14M | $13.12M | $15.73M |
| Total Operating Expenses | $10.05M | $13.84M | $13.27M | $9.42M | $15.73M | $17.54M | $17.99M | $20.35M |
| Operating Income | -$10.05M | $7.16M | -$13.27M | -$9.42M | -$15.73M | -$17.54M | -$17.99M | -$20.35M |
| EBITDA | -$8.79M | $9.61M | -$12.87M | -$9.02M | -$15.32M | -$17.14M | -$17.57M | -$19.91M |
| Interest Income | $183K | $277K | $433K | $564K | $697K | $850K | $997K | $1.31M |
| Interest Expense | $0 | $475K | $1.37M | $1.37M | $1.34M | $1.30M | $1.26M | $1.27M |
| Net Income | -$9.88M | $3.67M | -$13.53M | -$8.38M | -$16.37M | -$17.98M | -$18.09M | -$20.40M |
| Basic EPS | -$0.20 | $0.08 | -$0.28 | -- | -$0.36 | -$0.40 | -$0.40 | -- |
| Diluted EPS | -$0.20 | $0.08 | -$0.28 | -- | -$0.36 | -$0.40 | -$0.40 | -- |
| Basic Shares Outstanding | 48.6M | 48.6M | 48.6M | -- | 45.8M | 45.0M | 44.8M | -- |
| Diluted Shares Outstanding | 48.6M | 48.6M | 49.4M | -- | 45.8M | 45.0M | 44.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $57.05M | $111.0M | $134.3M | $129.3M | $157.5M | $92.57M |
| Cash & Short-Term Investments | $57.05M | $111.0M | $134.3M | $129.3M | $157.5M | $92.57M |
| Total Current Assets | $58.59M | $113.1M | $138.4M | $140.2M | $161.1M | $92.91M |
| Property, Plant & Equipment, Net | $4.69M | $6.32M | $7.96M | $8.99M | $2.91M | $651K |
| Other Non-Current Assets | $5.0K | $320K | $594K | $1.38M | $649K | $0 |
| Total Non-Current Assets | $10.81M | $13.86M | $36.46M | $20.05M | $18.18M | $3.48M |
| Total Assets | $69.40M | $126.9M | $174.8M | $160.2M | $179.2M | $96.40M |
| Accounts Payable | $754K | $3.04M | $1.34M | $1.22M | $2.04M | $1.02M |
| Deferred Revenue (Current) | $0 | $0 | $907K | $6.53M | $0 | -- |
| Other Current Liabilities | -- | -- | -- | $6.53M | $0 | $0 |
| Total Current Liabilities | $36.15M | $15.18M | $19.38M | $23.99M | $11.87M | $5.28M |
| Long-Term Debt | $32.09M | $32.09M | $40.00M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | $0 | $433K | $1.13M | $0 | -- |
| Other Non-Current Liabilities | -- | -- | $0 | $191K | $0 | $31K |
| Total Non-Current Liabilities | $8.44M | $38.36M | $44.08M | $13.92M | $14.59M | $1.90M |
| Total Liabilities | $44.59M | $53.54M | $63.46M | $37.91M | $26.46M | $7.18M |
| Total Debt (incl. Leases) | $41.52M | $43.08M | $52.60M | $14.68M | $15.66M | $2.54M |
| Common Stock | $5.0K | $5.0K | $4.0K | $3.0K | $2.0K | $2.0K |
| Retained Earnings | -$475.4M | -$414.6M | -$344.1M | -$306.7M | -$252.9M | -$51.87M |
| Total Stockholders' Equity | $24.80M | $73.39M | $111.4M | $122.3M | $152.8M | -$51.86M |
| Total Equity | $24.80M | $73.39M | $111.4M | $122.3M | $152.8M | -$51.86M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $41.87M | $21.99M | $46.45M | $57.05M | $65.71M | $77.60M | $92.04M | $111.0M |
| Cash & Short-Term Investments | $41.87M | $21.99M | $46.45M | $57.05M | $65.71M | $77.60M | $92.04M | $111.0M |
| Total Current Assets | $42.75M | $22.89M | $48.73M | $58.59M | $68.17M | $80.44M | $94.46M | $113.1M |
| Property, Plant & Equipment, Net | $0 | $1.26M | $4.29M | $4.69M | $5.09M | $5.49M | $5.90M | $6.32M |
| Other Non-Current Assets | $0 | $0 | $0 | $5.0K | $46K | $122K | $179K | $320K |
| Total Non-Current Assets | $0 | $1.26M | $9.29M | $10.81M | $11.45M | $12.13M | $12.78M | $13.86M |
| Total Assets | $42.75M | $24.16M | $58.02M | $69.40M | $79.63M | $92.57M | $107.2M | $126.9M |
| Accounts Payable | $2.43M | $1.94M | $3.57M | $754K | $1.08M | $2.77M | $986K | $3.04M |
| Deferred Revenue (Current) | $28.85M | -- | -- | $0 | -- | -- | -- | $0 |
| Total Current Liabilities | $35.99M | $7.86M | $38.52M | $36.15M | $17.60M | $15.17M | $11.67M | $15.18M |
| Long-Term Debt | -- | -- | $32.09M | $32.09M | $32.09M | $32.09M | $32.09M | $32.09M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $0 | $0 | $7.30M | $8.44M | $32.41M | $35.93M | $38.26M | $38.36M |
| Total Liabilities | $35.99M | $7.86M | $45.82M | $44.59M | $50.01M | $51.10M | $49.93M | $53.54M |
| Total Debt (incl. Leases) | -- | -- | $40.91M | $41.52M | $41.73M | $42.13M | $42.51M | $43.08M |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$495.1M | -$485.3M | -$488.9M | -$475.4M | -$467.0M | -$450.7M | -$432.7M | -$414.6M |
| Total Stockholders' Equity | $6.76M | $16.29M | $12.20M | $24.80M | $29.61M | $41.46M | $57.31M | $73.39M |
| Total Equity | $6.76M | $16.29M | $12.20M | $24.80M | $29.61M | $41.46M | $57.31M | $73.39M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$60.82M | -$70.52M | -$37.37M | -$53.81M | -$49.98M | -$15.04M |
| Depreciation & Amortization | $1.63M | $1.81M | $1.76M | $1.10M | $216K | $150K |
| Stock-Based Compensation | $6.25M | $8.83M | $8.01M | $7.40M | $4.09M | $632K |
| Change in Payables | -- | -- | -- | -$883K | $1.01M | $388K |
| Operating Cash Flow | -$60.29M | -$56.19M | -$32.61M | -$40.60M | -$42.88M | -$18.62M |
| Capital Expenditure | $0 | -$254K | -$769K | -$3.61M | -$498K | -$560K |
| Free Cash Flow | -$60.29M | -$56.44M | -$33.38M | -$44.21M | -$43.37M | -$19.18M |
| Investing Cash Flow | $0 | -$254K | -$769K | -$3.61M | -$498K | -$560K |
| Common Stock Issued | $5.94M | $23.58M | $18.33M | $15.74M | $0 | -- |
| Financing Cash Flow | $6.03M | $13.08M | $58.43M | $15.91M | $109.4M | $93.86M |
| Net Change in Cash | -$54.26M | -$43.36M | $25.05M | -$28.30M | $66.05M | $74.67M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$9.88M | $3.67M | -$13.53M | -$8.38M | -$16.37M | -$17.98M | -$18.09M | -$20.40M |
| Depreciation & Amortization | $1.26M | $2.45M | $398K | $400K | $402K | $406K | $426K | $442K |
| Stock-Based Compensation | $344K | $419K | $929K | $1.21M | $1.23M | $1.79M | $2.01M | $1.91M |
| Operating Cash Flow | -$8.97M | $6.63M | -$10.60M | -$11.02M | -$15.16M | -$15.16M | -$18.95M | -$14.25M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$123K |
| Free Cash Flow | -- | -- | -- | -$11.02M | -$15.16M | -$15.16M | -$18.95M | -$14.38M |
| Investing Cash Flow | -- | -- | -- | $0 | $0 | $0 | $0 | -$123K |
| Common Stock Issued | -- | -- | -- | $2.32M | $3.27M | $347K | $0 | $2.48M |
| Financing Cash Flow | -- | -- | -- | $2.37M | $3.27M | $388K | $0 | $2.55M |
| Net Change in Cash | $19.88M | -$25.37M | -$10.60M | -$8.66M | -$11.88M | -$14.78M | -$18.95M | -$11.83M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -245.2% | -96.1% | -33.6% | -44.0% | -32.7% | -- |
| Return on Assets (ROA) | -87.6% | -55.6% | -21.4% | -33.6% | -27.9% | -15.6% |
| Current Ratio | 1.62x | 7.45x | 7.14x | 5.84x | 13.56x | 17.58x |
| Quick Ratio | 1.58x | 7.31x | 6.93x | 5.39x | 13.27x | 17.52x |
| Debt to Equity | 1.67x | 0.59x | 0.47x | 0.12x | 0.10x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -416.0% | -212.5% | -461.1% | -245.2% | -246.0% | -176.4% | -126.4% | -96.1% |
| Return on Assets (ROA) | -65.8% | -143.3% | -97.0% | -87.6% | -91.5% | -79.0% | -67.5% | -55.6% |
| Current Ratio | 1.19x | 2.91x | 1.27x | 1.62x | 3.87x | 5.30x | 8.09x | 7.45x |
| Quick Ratio | 1.16x | 2.80x | 1.21x | 1.58x | 3.73x | 5.11x | 7.89x | 7.31x |
| Debt to Equity | -- | -- | 3.35x | 1.67x | 1.41x | 1.02x | 0.74x | 0.59x |